At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
In Brief
An observational study for Colitis, Ulcerative and 2 related conditions. Completed, enrolled 13 participants across 1 site.
Detailed Summary
To assess if infliximab drug levels in subjects with Ulcerative Colitis predict risk of colectomy rate. Additionally, the investigators will estimate an optimal day 4 infliximab level based on the study results.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColitis, Ulcerative, Inflammatory Bowel Disease, IBD
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedMay 2015
Primary CompletionDec 2019
TodayJul 2026
First PostedMay 8, 2015
Enrollment StartMay 1, 2015
Primary CompletionDec 4, 2019
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 11.2 years ago